Anebulo Pharmaceuticals I...

NASDAQ: ANEB · Real-Time Price · USD
2.51
0.07 (2.87%)
At close: Aug 15, 2025, 3:59 PM
2.50
-0.40%
After-hours: Aug 15, 2025, 04:10 PM EDT

Anebulo Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-8.2M -11.73M -6.83M -30.25M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
758.88K 884.72K 480.66K 199.95K
Other Working Capital
-421.14K -153.72K 637K -1.56M
Other Non-Cash Items
151.23K 731.01K 209.88K 26.63M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-799.26K 1.16M 907.78K -1.45M
Operating Cash Flow
-8.09M -9.68M -5.44M -4.87M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a -201.29K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-62.35K -264.68K n/a -821.63K
Financial Cash Flow
-62.35K 6.38M n/a 21.83M
Net Cash Flow
-8.15M -3.3M -5.44M 16.96M
Free Cash Flow
-8.09M -9.68M -5.44M -4.87M